<PAPER>
  <mode2 name="ehp7_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="publisher-id">EHP</journal-id>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Environ. Health Perspect.</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="publisher-id">ehp0116-000930</article-id>
        <article-id pub-id-type="doi">10.1289/ehp.11068</article-id>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject/>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Brevetoxin Forms Covalent DNA Adducts in Rat Lung Following Intratracheal Exposure<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" corresp="yes" xlink:type="simple">
            <name name-style="western">
              <surname>Radwan</surname>
              <given-names>Faisal F.Y.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp0116-000930">
              <sup>1</sup>
            </xref>
            <xref ref-type="aff" rid="af2-ehp0116-000930">
              <sup>2</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Ramsdell</surname>
              <given-names>John S.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp0116-000930">
              <sup>1</sup>
            </xref>
          </contrib>
          <aff id="af1-ehp0116-000930">
            <label>1</label>
            <addr-line> Marine Biotoxins Program, Center for Coastal Environmental Health and Biomolecular Research, National Oceanic and Atmospheric Administration/National Ocean Service, Charleston, South Carolina, USA</addr-line>
          </aff>
          <aff id="af2-ehp0116-000930">
            <label>2</label>
            <addr-line> Sohag University, Faculty of Science, Sohag, Egypt</addr-line>
          </aff>
        </contrib-group>
        <author-notes>
          <corresp>Address correspondence to J.S. Ramsdell, Harmful Algal Bloom &amp; Analytical Response Branch, NOAA, 219 Fort Johnson Rd., Charleston, SC 29412, USA. Telephone: (843) 762&#8211;8510. Fax: (843) 762&#8211;8700. E-mail: john.ramsdell@noaa.gov</corresp>
          <fn id="fn1">
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>24</day>
          <month>3</month>
          <year>2008</year>
        </pub-date>
        <volume>116</volume>
        <issue>7</issue>
        <fpage>930</fpage>
        <lpage>936</lpage>
        <history>
          <date date-type="received">
            <day>14</day>
            <month>11</month>
            <year>2007</year>
          </date>
          <date date-type="accepted">
            <day>21</day>
            <month>3</month>
            <year>2008</year>
          </date>
        </history>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/" xlink:type="simple">
          <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
        </license>
        <permissions>
          <copyright-year>2008</copyright-year>
          <copyright-holder/>
        </permissions>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Human exposure to brevetoxins produced by the red tide organism, <italic>Karenia brevis</italic>, is an increasing public health concern.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
              <s sid="3">Using <italic>in vitro</italic> exposure of rat liver cells to brevetoxin B (PbTx-2), the primary toxin product of <italic>K. brevis</italic>, we previously showed that it formed C<sub>27,28</sub>-epoxy brevetoxin metabolites capable of covalently binding to nucleic acids, a common initiation step for carcinogenesis.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objective</title>
            <p>
              <s sid="4">This study was undertaken to evaluate nucleic acid adduction in lung following <italic>in vitro</italic> and <italic>in vivo</italic> brevetoxin exposures.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="5">To clarify reactions of brevetoxin epoxide with DNA, we analyzed reaction products of PbTx-6 (a C<sub>27,28</sub> epoxide metabolite of brevetoxin B) with nucleosides.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
              <s sid="6">We also analyzed adducts from nucleic acid hydrolysates of isolated rat lung cells treated with PbTx-2 or PbTx-6 <italic>in vitro</italic> and lung tissue from rats after intratracheal exposure to PbTx-2 or PbTx-6 at 45 &#956;g toxin/kg body weight.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="7">Our results indicate that PbTx-2 forms DNA adducts with cytidine after treatment of isolated lung cells, and forms DNA adducts with adenosine and guanosine after intratracheal exposure.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusions</title>
            <p>
              <s sid="8">These results are consistent with metabolic activation of highly reactive brevetoxin intermediates that bind to nucleic acid.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
              <s sid="9">These findings provide a basis for monitoring exposure and assessing the hazard associated with depurination of brevetoxin&#8211;nucleotide adducts in lung tissue.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>brevetoxin</kwd>
          <kwd>DNA adducts</kwd>
          <kwd>epoxidation</kwd>
          <kwd>harmful algal bloom</kwd>
          <kwd>Karenia brevis</kwd>
          <kwd>lung</kwd>
          <kwd>metabolism</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="10"><italic>Karenia brevis</italic>, formerly <italic>Gymnodinium breve</italic>, a brevetoxin-producing dinoflagellate, is recognized as the major harmful algae forming the red tide blooms in the Gulf of Mexico (<xref ref-type="bibr" rid="b11-ehp0116-000930">Davis 1948</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="11">Two classes of brevetoxins were originally isolated from <italic>K. brevis</italic> by high pressure liquid chromatography (<xref ref-type="bibr" rid="b27-ehp0116-000930">Risk et al. 1979</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="12">Structural analysis of these fractions identified two backbone structures, containing either 11 (brevetoxin-B) or 10 (brevetoxin-A) fused cyclic ether rings (<xref ref-type="bibr" rid="b20-ehp0116-000930">Lin et al. 1981</xref>; <xref ref-type="bibr" rid="b31-ehp0116-000930">Shimizu et al. 1986</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="13">Each backbone structure has similar functional groups and is subject to similar metabolic modifications (<xref ref-type="bibr" rid="b34-ehp0116-000930">Wang et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="14">Brevetoxins bind to voltage-gated sodium channels to alter gating transitions interfering with the sensitive movements that transition the channel&#8217;s closed, open, and inactivated states (<xref ref-type="bibr" rid="b8-ehp0116-000930">Catterall and Risk 1981</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
        <s sid="15">The initial actions of brevetoxins lead to nerve activation; within a few seconds of nerve activation, transient repetitive neuronal discharges are followed by action potential depression and eventually by a complete blockade of neuronal excitability (<xref ref-type="bibr" rid="b16-ehp0116-000930">Huang et al. 1984</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="16">The direct consumption of brevetoxin-laden shellfish causes the food poisoning referred to as neurotoxic shellfish poisoning (NSP) in humans (<xref ref-type="bibr" rid="b21-ehp0116-000930">McFarren et al. 1965</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="17">NSP has become a rare phenomenon, even with the frequent occurrence of red tide events, in large part due to effective monitoring and management of shellfish harvest.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="18">However, inhalation of airborne brevetoxins at beaches remains common, and the occupational and recreational hazards have been the subject of recent investigations (<xref ref-type="bibr" rid="b2-ehp0116-000930">Backer et al. 2003</xref>, <xref ref-type="bibr" rid="b3-ehp0116-000930">2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="19">Experimental exposure of brevetoxin aerosols was first demonstrated by <xref ref-type="bibr" rid="b36-ehp0116-000930">Woodcock (1948)</xref>, and in the last decade several studies have characterized the toxicokinetics and adverse effects of brevetoxins after intratracheal exposure of rats or sheep (<xref ref-type="bibr" rid="b1-ehp0116-000930">Abraham et al. 2005</xref>; <xref ref-type="bibr" rid="b4-ehp0116-000930">Benson et al. 1999</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="20">During this time, various animal and tissue explant models have been used to discriminate the molecular actions of brevetoxins on voltage-gated sodium channels in lung smooth muscle, autonomic nerve, and central respiratory centers (<xref ref-type="bibr" rid="b26-ehp0116-000930">Ramsdell 2008</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
        <s sid="21">Exposure to brevetoxin-containing aerosols has also been shown to cause severe allergic reactions in asthmatic patients (<xref ref-type="bibr" rid="b12-ehp0116-000930">Fleming et al. 2007</xref>; <xref ref-type="bibr" rid="b18-ehp0116-000930">Kirkpatrick et al. 2006</xref>), but to date the adverse effects of direct exposure to the respiratory tract have not been found to be severe in healthy subjects.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="22">A second potentially adverse mode of brevetoxin action may be oxidative damage as result of brevetoxin metabolism.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
        <s sid="23">Previous research has shown that the brevetoxin B (PbTx-2) is widely metabolized after systemic administration to rats, after exposure to freshly isolated rat hepatocytes, and after treatment with cDNA-expressed rat cytochrome P-450 enzymes (<xref ref-type="bibr" rid="b24-ehp0116-000930">Radwan and Ramsdell 2006</xref>; <xref ref-type="bibr" rid="b25-ehp0116-000930">Radwan et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
        <s sid="24">Metabolic reactions were observed on the A-ring, H-ring, and R-group of the terminal K-ring.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
        <s sid="25">They included hydrolysis (A-ring), epoxidation (H-ring), oxidation (R-group aldehyde), reduction (R-group aldehyde and &#945;, &#946;-unsaturated carbon), and peptide conjugation (R-group &#945;,&#946;-unsaturated aldehyde) (<xref ref-type="fig" rid="f1-ehp0116-000930">Figure 1</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
        <s sid="26">The epoxide metabolites are of interest because epoxides are highly reactive intermediates that react with nucleophilic sites to form covalent adducts with cellular macromolecules such as DNA and proteins (<xref ref-type="bibr" rid="b19-ehp0116-000930">Koskinen and Plna 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="27">The large variability of phase I or II enzymes among animal species and their target organs defines a key question concerning organ-specific toxicity.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
        <s sid="28">Whether the actual target has the capacity to activate (or efficiently deactivate) chemicals is a key factor in susceptibility to toxin adduction.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        <s sid="29">Lung is a target organ for the toxicity of most inhaled toxins.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
        <s sid="30">Occupational, accidental, or prolonged pulmonary exposure to elevated concentrations of brevetoxins is now the primary route for toxicity in humans during red tide blooms.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
        <s sid="31">Yet the mechanism by which lung cells metabolize brevetoxin to reduce its potential toxicity is still unknown.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
        <s sid="32">Results of several studies indicate that a variety of xenobiotic-metabolizing cytochromes [such as cytochrome P450 (CYP) 1A and CYP3A families] in the human lung and in lung-derived cell lines contributes to the <italic>in situ</italic> activation of pulmonary toxins (<xref ref-type="bibr" rid="b7-ehp0116-000930">Castell et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
        <s sid="33">Lung cells also express phase II enzymes such as epoxide hydrolase, UGT1A (glucuronyl transferase), and GST-P1 (glutathione <italic>S</italic>-transferase), which largely act as detoxifying enzymes.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="34">Adduct formation is a key step in inducing genotoxicity as a result of exposure to chemicals and metabolites that damage nucleic acid.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
        <s sid="35">The present study aimed to investigate brevetoxin adduction with nucleic materials in the lungs of exposed rats and thus to provide insight into DNA adduction by brevetoxins following metabolic activation.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/></s>
        <s sid="36">Detection of brevetoxin&#8211;nucleic acid adduction has pharmacological and risk assessment importance and should provide a foundation for biological monitoring of human exposure to such genotoxic environmental agents.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec sec-type="materials">
          <title>Materials</title>
          <p>
            <s sid="37">Brevetoxins PbTx-2 (MH<sup>+</sup>, <italic>m/z</italic> 895) and PbTx-6 (MH<sup>+</sup>, <italic>m/z</italic> 911), derived from <italic>K. brevis</italic> cultures [purity reported by vendor to be &#8805; 95% by high performance liquid chromatography (HPLC)], were purchased from EMD Chemicals, Inc. (San Diego, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="38">Nucleosides guanosine and cytosine were purchased from Calbiochem (EMD Biosciences, Inc., San Diego, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="39">Total nucleic acid was isolated using DNeasy Tissue Kit produced by Qiagen Inc. (Germantown, MD, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
            <s sid="40">Dulbecco&#8217;s modified Eagle medium (DMEM) was purchased from Invitrogen (Carlsbad, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="41">Rat lung cells (CCL-192/RFL-6) were purchased from the American Type Culture Collection (Manassas, VA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="42">All other analytical or molecular biologic grade chemicals used in this study were purchased from either Sigma Chemical Co. (St. Louis, MO, USA) or Fisher Scientific (Suwanee, GA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Semisynthesis of nucleoside adducts with PbTx-6</title>
          <p>
            <s sid="43">Reaction mixtures (200 &#956;L total volume) of PbTx-6 (200 &#956;M) were incubated with aliquots of 50 mM equivalents of individual nucleosides prepared in 100 mM phosphate buffer at pH 7.4.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="44">The incubation was carried out in a shaking bath overnight at 37&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="45">The reaction mixture was centrifuged at 900 &#215; <italic>g</italic> for 5 min to remove any particulates.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
            <s sid="46">We isolated the brevetoxin nucleoside adducts in the supernatant using a 500 mg C-18 cartridge (Varian; Palo Alto, CA, USA) previously conditioned with 3 mL methanol followed by 3 mL distilled water.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
            <s sid="47">Reactions were loaded, washed with 3 mL 10% methanol, and adducts were eluted with 5 mL 85% methanol.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
            <s sid="48">We dried and reconstituted adducts in 50% methanol for further radioimmunoassay (RIA) and HPLC/mass spectrometry (MS) analyses.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title><italic>In vitro</italic> treatment of lung cells with PbTx-2 and PbTx-6</title>
          <p>
            <s sid="49">We prepared toxins in methanol and diluted them in the culture medium (DMEM) so that the final methanol concentration was 1.5% (vol/vol); we then preincubated the preparation at 37&#176;C for 10 min.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
            <s sid="50">Aliquots of rat lung cell culture suspension were transferred into new incubation wells and preincubated at 37&#176;C for 10 min.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
            <s sid="51">We initiated toxin exposure by adding PbTx-2&#8211; or PbTx-6&#8211;enriched medium to a well containing cells.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
            <s sid="52">The final incubation mixture contained 35 &#956;M of toxin and a cell count of approximately 1.1 &#215; 10<sup>6</sup> cells/mL.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/></s>
            <s sid="53">Control reactions were preformed by incubating cells in brevetoxin-free medium.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/></s>
            <s sid="54">We determined cell viability (&gt; 86%) before exposure using the trypan blue (0.4%) exclusion test.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp18" novelty="None" advantage="None"/></s>
            <s sid="55">All incubations were performed at 37&#176;C for 18 hr in a 5% CO<sub>2</sub> humidified atmosphere.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp19" novelty="None" advantage="None"/></s>
            <s sid="56">Cells were pelleted by centrifugation at 1,500 &#215; <italic>g</italic> for 10 min and immediately frozen at &#8722;80&#176;C for further nucleic acid extraction.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp20" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Rat intratracheal exposures to PbTx-2 and PbTx-6</title>
          <p>
            <s sid="57">Brevetoxin treatments were carried out at Charles River Laboratories Inc., (Horsham, PA, USA) using 12-week-old Charles River male rats [Crl:CD(SD)IGS BR VAF/Plus; 225&#8211;250 g body weight].<CoreSc1 atype="GSC" type="Exp" conceptID="Exp21" novelty="None" advantage="None"/></s>
            <s sid="58">Animals were separated into three groups of five rats per group and identified using Monel self-piercing ear tags.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp22" novelty="None" advantage="None"/></s>
            <s sid="59">Brevetoxins dissolved in 10% methanol were further diluted in physiological saline containing 0.01% Emulphor EL-620 (GAF Corp., New York, NY, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp23" novelty="None" advantage="None"/></s>
            <s sid="60">Rats in the treatment groups were administered PbTx-2 (group 1) or PbTx-6 (group 2) at 45 &#956;g/kg body weight through intratracheal instillation.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp24" novelty="None" advantage="None"/></s>
            <s sid="61">We determined the dosage by a preliminary range-finding study of the maximally tolerable dose for PbTx-2 as defined by labored breathing not greater than 30 min after exposure.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp25" novelty="None" advantage="None"/></s>
            <s sid="62">Briefly, rats were anesthetized using 5% isoflurane in O<sub>2</sub> and intubated intratracheally as described previously (<xref ref-type="bibr" rid="b22-ehp0116-000930">Medinsky et al. 1986</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp26" novelty="None" advantage="None"/></s>
            <s sid="63">The doses, in a volume of 0.15 mL saline, were instantaneously delivered directly to the lung by a Luer-Lok syringe through a 16-gauge catheter.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp27" novelty="None" advantage="None"/></s>
            <s sid="64">Rats were killed 24 hr after treatment, and the lungs were collected immediately and kept frozen at &#8722;80&#176;C until use.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp28" novelty="None" advantage="None"/></s>
            <s sid="65">Control rats received brevetoxin-free vehicle solution (group 3).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp29" novelty="None" advantage="None"/></s>
            <s sid="66">Animal use was conducted according to Good Laboratory Practice Procedures, and the animals were treated humanely and with regard for alleviation of suffering.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp30" novelty="None" advantage="None"/></s>
            <s sid="67">The experimental protocol was approved by the Charles River Laboratories Institutional Animal Care and Use Committee.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp31" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Nucleic acid extraction and digestion</title>
          <p>
            <s sid="68">We isolated nucleic acid from rat lung using Qiagen Genomic-tips, essentially as described by the manufacturer, with the following modifications.<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
            <s sid="69">Cultured cells (~ 3.3 &#215; 10<sup>6</sup>/test) were thawed and resuspended in 200 &#956;L phosphate buffer (0.1 M).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp32" novelty="None" advantage="None"/></s>
            <s sid="70">Lung tissues were minced into smaller pieces in a Petri dish containing Dulbecco&#8217;s phosphate-buffered saline (PBS) and 20 mM EDTA, pH 7.8, on ice.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp33" novelty="None" advantage="None"/></s>
            <s sid="71">We transferred 25-mg pieces to a 1.5-mL centrifuge tube and rinsed them at least three times in PBS.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp34" novelty="None" advantage="None"/></s>
            <s sid="72">Cells or lung tissues were initially digested with protease K for 4 hr at 65&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp35" novelty="None" advantage="None"/></s>
            <s sid="73">The mixture was loaded into the DNeasy spin column placed in a 2-mL collection tube.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp36" novelty="None" advantage="None"/></s>
            <s sid="74">Unbound substances were collected during washing process.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp37" novelty="None" advantage="None"/></s>
            <s sid="75">We determined the purity of the eluted nucleic acid extract by the ratio of absorbance at 260 nm (A<sub>260</sub>) and A<sub>280</sub> (the accepted purity ratios A<sub>260</sub>/A<sub>280</sub> were ~ 1.85).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp38" novelty="None" advantage="None"/></s>
            <s sid="76">We determined the concentration based on a solution containing 50 &#956;g/mL of double-stranded DNA having an absorbency (optical density; OD) of 1.0 at a wavelength of 260.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp39" novelty="None" advantage="None"/></s>
            <s sid="77">Extracts were stored at &#8722;80&#176;C until use.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp40" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Nucleic acid hydrolysis and adduct purification</title>
          <p>
            <s sid="78">Extracts were acid hydrolyzed in 0.1 N HCl at 75&#176;C for 30 min (<xref ref-type="bibr" rid="b15-ehp0116-000930">Hertzog et al. 1980</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp41" novelty="None" advantage="None"/></s>
            <s sid="79">We then adjusted the pH to about 4.5 with 5 N NH<sub>4</sub>OH.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp42" novelty="None" advantage="None"/></s>
            <s sid="80">The nucleic acid hydrolysates were redissolved in 10% methanol and loaded onto a previously conditioned SPE C-18 cartridge (500 mg; Varian).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp43" novelty="None" advantage="None"/></s>
            <s sid="81">The cartridge was washed with 5 mL distilled water, and brevetoxin adducts were then eluted with 10 mL 85% methanol.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp44" novelty="None" advantage="None"/></s>
            <s sid="82">The eluate containing brevetoxin nucleoside adducts was concentrated to dryness under nitrogen stream.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp45" novelty="None" advantage="None"/></s>
            <s sid="83">We resuspended the dried adducts in 100 &#956;L of 50% methanol for immediate RIA or liquid chromatography (LC)/MS analyses.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp46" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>RIA</title>
          <p>
            <s sid="84">We performed an RIA selective for toxins with the B-type backbone brevetoxin as described previously (<xref ref-type="bibr" rid="b37-ehp0116-000930">Woofter et al. 2003</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
            <s sid="85">Tests were carried out in borosilicate glass tubes using antibodies raised in sheep immunized with PbTx-2&#8211;fetuin conjugate (<xref ref-type="bibr" rid="b13-ehp0116-000930">Garthwaite et al. 2001</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp47" novelty="None" advantage="None"/></s>
            <s sid="86">Assays were conducted in RIA buffer, a PBS containing 0.01% Emulphor-EL 620 with a final volume of 500 &#956;L/test.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp48" novelty="None" advantage="None"/></s>
            <s sid="87">Briefly, 5 &#956;L of adduct extract, or PbTx-3 (the PbTx-2 terminal alcohol reduction product) standard set (from 0.01 to 1,000 nM) was incubated with 20 &#956;L anti-PbTx antiserum (1:4,000) in RIA buffer for 1 hr at 25&#176;C.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp49" novelty="None" advantage="None"/></s>
            <s sid="88">Thereafter, 0.4 nM of the <sup>3</sup>H-PbTx-3 tracer was added, and the incubation proceeded for another hour.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp50" novelty="None" advantage="None"/></s>
            <s sid="89">Finally, we added 100 &#956;L Sac-Cel (IDS Diagnostics, Fountain Hills, AZ, USA) to each of the assay tubes allowing the separation of the bound and unbound brevetoxin.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp51" novelty="None" advantage="None"/></s>
            <s sid="90">The Sac-Cel mixture was filtered onto 25-mm diameter GF/B glass fiber filters (Whatman, Newton, MA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp52" novelty="None" advantage="None"/></s>
            <s sid="91">The filters were immersed in 5 mL Scintiverse (Fisher, Suwannee, GA, USA) for 18 hr, and the radioactivity was counted on a Tri-Carb 3100TR liquid scintillation counter (Packard Bioscience Company, Meriden, CT, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp53" novelty="None" advantage="None"/></s>
            <s sid="92">Standard curves were constructed for each individual experiment, and results were expressed as PbTx-3 equivalents per microgram DNA in the original extract.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp54" novelty="None" advantage="None"/></s>
            <s sid="93">Extracts from controls did not have measurable matrix interference.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
            <s sid="94">The assay limit of detection for RIA of PbTx-3 was about 0.5 ng/mL.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp55" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>LC/MS analyses</title>
          <p>
            <s sid="95">Adduct formation was analyzed using a Shimadzu VP HPLC system equipped with a Hypersil Beta-Basic C-18 column (1 &#215; 50 mm, 3 &#956;m; Thermo Electron Co., San Jose, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp56" novelty="None" advantage="None"/></s>
            <s sid="96">The mobile phase consisted of water (A) and methanol (B) in a binary system, with 0.18% formic acid as an additive.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp57" novelty="None" advantage="None"/></s>
            <s sid="97">The elution gradient was 45&#8211;75% B for 30 min, and the flow rate was 0.l mL/min.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp58" novelty="None" advantage="None"/></s>
            <s sid="98">We analyzed adduct formation using the Q-STAR quadropole/time-of-flight mass spectrometer (Applied Biosystems/MDS SCIEX, Foster City, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp59" novelty="None" advantage="None"/></s>
            <s sid="99">The mass spectrometer detected positive ions over the mass range <italic>m/z</italic> 300&#8211;1,400 or 100&#8211;1,400 atomic mass units (amu) at an orifice potential of 30 V. Selective molecular ions of nucleoside modified with brevetoxin, the molecular ions arising from the elimination of the ribose moiety from the parent compounds, and the loss of respective nucleobase were monitored.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
            <s sid="100">Ultraviolet chromatograms were also recorded at a wavelength of 260 nm.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp60" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <sec>
          <title>Semisynthesis of PbTx-6 nucleoside adducts</title>
          <p>
            <s sid="101">RIA of PbTx-6 extracted from the incubation mixture with nucleosides identified a reduction in recovered brevetoxin immuno-reactivity, consistent with the formation of brevetoxin nucleoside adducts (<xref ref-type="fig" rid="f2-ehp0116-000930">Figure 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
            <s sid="102"><xref ref-type="fig" rid="f3-ehp0116-000930">Figure 3A&#8211;C</xref> shows the LC/MS peak of nucleoside adducts that were not observed in control mixtures.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
            <s sid="103">Only a single peak of brevetoxin adduct was identified with each of these nucleosides.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
            <s sid="104">The molecular ion of each adduct indicated that one molecule of PbTx-6 was adducted to each nucleoside.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            <s sid="105">Peaks had molecular ions corresponding to adduction products between PbTx-6 and nucleosides: retained at 11.8 min (<italic>m/z</italic> 1,154) for brevetoxin&#8211;cytidine (<xref ref-type="fig" rid="f3-ehp0116-000930">Figure 3A</xref>) and at about 15 min (<italic>m/z</italic> 1,194) for brevetoxin&#8211;guanosine adduct (<xref ref-type="fig" rid="f3-ehp0116-000930">Figure 3B</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/></s>
            <s sid="106">Unbound PbTx-6 (<italic>m/z</italic> 911) was retained at about 18.5 min, identical for both control and treatments (<xref ref-type="fig" rid="f3-ehp0116-000930">Figure 3C</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/></s>
            <s sid="107">Fragmentation of nucleoside adducts resulted in initial elimination of the ribose moiety from the parent compounds: <italic>m/z</italic> 1,154 to <italic>m/z</italic> 1,022 for brevetoxin&#8211;cytidine and <italic>m/z</italic> 1,194 to <italic>m/z</italic> 1,062 for brevetoxin&#8211;guanosine.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/></s>
            <s sid="108">The loss of respective nucleobase was monitored in both adducts giving rise to ions <italic>m/z</italic> 112 or <italic>m/z</italic> 152 for cytosine or guanine, respectively.<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
            <s sid="109">Fragments of nucleobase imine were seen as <italic>m/</italic>z 124 (C=N<sup>4</sup>&#8211;) and <italic>m/</italic>z 164 (C=N<sup>2</sup>&#8211;) for cytosine or guanine, respectively.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/></s>
            <s sid="110">PbTx-6 was characterized by its daughter fragments <italic>m/</italic>z 857 and <italic>m/z</italic> 473 (<xref ref-type="fig" rid="f3-ehp0116-000930">Figure 3C</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Adduct formation after <italic>in vitro</italic> exposure</title>
          <p>
            <s sid="111">Lung cells exposed to PbTx-2 showed an approximate 4-fold increase in the amount of adduct compared to PbTx-6 treatment.<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
            <s sid="112">RIA showed 115.5 &#177; 31 pg PbTx-6 equivalents per microgram DNA for cells exposed to PbTx-2 and 34.1 &#177; 3 pg/&#956;g DNA of cells exposed to PbTx-6.<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
            <s sid="113">LC/MS analysis of extracts of PbTx-2 exposure revealed molecular ions corresponding to products between brevetoxin and cytidine.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
            <s sid="114">These ions included <italic>m/z</italic> 1,022 (brevetoxin-nucleobase after losing the sugar moiety) and cytosine <italic>m/z</italic> 112 and cytosine <italic>N</italic><sup>4</sup> imine <italic>m/z</italic> 124 (<xref ref-type="fig" rid="f4-ehp0116-000930">Figure 4</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/></s>
            <s sid="115">Neither adduct parent molecule nor its legitimate sugar-free ion fragment was detected in PbTx-6 exposures.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Adduct formation after <italic>in vitro</italic> exposure</title>
          <p>
            <s sid="116">A considerable amount of brevetoxin activity was retained in lung tissue 24 hr after exposure.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/></s>
            <s sid="117">An average of 136.3 ng PbTx-3 equivalents/g of lung tissue was measured for PbTx-2, while almost 2-fold more was measured in PbTx-6&#8211;exposed rats.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/></s>
            <s sid="118">RIA analyses of the nucleic acid hydrolysate showed about 4-fold greater adduct formation caused by PbTx-2 exposure (<xref ref-type="fig" rid="f5-ehp0116-000930">Figure 5</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
            <s sid="119">Further LC/MS analysis of the nucleic acid hydrosylate of PbTx-2&#8211;exposed lung revealed three molecular ions corresponding to brevetoxin adducts with nucleosides.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
            <s sid="120">The brevetoxin&#8211;guanosine adduct retained around 16 min (<italic>m/z</italic> 1,194) (<xref ref-type="fig" rid="f6-ehp0116-000930">Figure 6A</xref>), brevetoxin&#8211;adenine (<italic>m/z</italic> 1,046) retained at about 14 min (<xref ref-type="fig" rid="f6-ehp0116-000930">Figure 6B</xref>), and the brevetoxin&#8211;adenosine adduct retained at about 10.7 min (<italic>m/z</italic> 1,178; <xref ref-type="fig" rid="f6-ehp0116-000930">Figure 6C</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/></s>
            <s sid="121">Fragmentation spectra of nucleosidic adducts showed initial elimination of the sugar moiety to give daughter compounds: <italic>m/z</italic> 1,194 to <italic>m/z</italic> 1,062 for brevetoxin&#8211;guanosine and <italic>m/z</italic> 1,178 to <italic>m/z</italic> 1,042 for brevetoxin&#8211;guanosine.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
            <s sid="122">The loss of respective nucleobase was monitored in both adducts giving rise to ions <italic>m/z</italic> 152 or <italic>m/z</italic> 136 for guanine or adenine, respectively.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/></s>
            <s sid="123">Fragments of nucleobase imine were seen as <italic>m/</italic>z 164 (C=N<sup>2</sup>&#8211;) and <italic>m/</italic>z 148 (C=N<sup>6</sup>&#8211;).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/></s>
            <s sid="124">We could not detect adduct formation in hydrolysate extracts from PbTx-6 exposures using similar LC/MS conditions.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="125">Brevetoxin, the red tide toxin, is well characterized for its neurotoxic toxic effects mediated by the voltage-gated sodium channel that are manifest in NSP (<xref ref-type="bibr" rid="b26-ehp0116-000930">Ramsdell 2008</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
          <s sid="126">Respiratory exposure to seawater aerosols containing brevetoxins leads to a different constellation of effects (<xref ref-type="bibr" rid="b3-ehp0116-000930">Backer et al. 2005</xref>), some which are consistent with activation of voltage-gated sodium channels, whereas others may involve inflammatory reaction pathways (<xref ref-type="bibr" rid="b5-ehp0116-000930">Bossart et al. 1998</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="127">Brevetoxins can also lead to potential genotoxic effects.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
          <s sid="128"><italic>In vitro</italic> studies with human lymphocytes indicated that brevetoxins cause single-stranded and and double-stranded DNA breaks (<xref ref-type="bibr" rid="b28-ehp0116-000930">Sayer et al. 2005</xref>), and a follow-up study in Chinese hamster ovary cells reported that brevetoxin causes chromosomal aberrations (<xref ref-type="bibr" rid="b29-ehp0116-000930">Sayer et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="129">Systemic absorption of brevetoxins by mammals leads to rapid metabolism to produce more readily excreted polar products (<xref ref-type="bibr" rid="b25-ehp0116-000930">Radwan et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
          <s sid="130">The initial, or phase I reactions of brevetoxin include oxidation, reduction, hydrolysis, and epoxidation (<xref ref-type="bibr" rid="b24-ehp0116-000930">Radwan and Ramsdell 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="131">Epoxidation of the H-ring of brevetoxin B leads to a series of reactive intermediates that are capable of covalently binding with DNA or causing oxidative DNA damage.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="132">Formation of reactive intermediates is an initial step in the carcinogenic mechanisms of other well-known natural toxins such as aflatoxin (<xref ref-type="bibr" rid="b14-ehp0116-000930">Groopman et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="133">In the present study we examined the subsequent step in this progression&#8212;namely, the formation of brevetoxin&#8211;nucleoside adducts in lung after intratracheal exposure to brevetoxins.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
          <s sid="134">Adduct formation is a key step in inducing genotoxicity as a result of exposure to nucleic acid-damaging chemicals and metabolites.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
        </p>
        <sec>
          <title>Mechanism for brevetoxin&#8211;DNA adduct formation</title>
          <p>
            <s sid="135">We focused on brevetoxin B analogs; however, similar processes can be expected for brevetoxin A analogs.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
            <s sid="136">The initial brevetoxin B produced by the algae has a reactive &#945;,&#946;-unsaturated aldehyde extending from the terminal K-ring and has been designated as PbTx-2.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="None" advantage="None"/></s>
            <s sid="137">PbTx-2 is also subject to epoxidation, in the 27, 28 position of the H-ring designated PbTx-6, which as been found both in algal cells (<xref ref-type="bibr" rid="b10-ehp0116-000930">Chou et al. 1985</xref>) and as a metabolic product of PbTx-2 in liver cells (<xref ref-type="bibr" rid="b24-ehp0116-000930">Radwan and Ramsdell 2006</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj7" novelty="None" advantage="None"/></s>
            <s sid="138">In this article, we first described the semisynthesis of brevetoxin&#8211;nucleic acid adducts produced from reactions of PbTx-6 with cytosine and guanosine.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj8" novelty="None" advantage="None"/></s>
            <s sid="139">Reaction of PbTx-6 with nucleosides was noted by a decrease in toxin activity in the assay mixture compared to the control, which suggests that nucleosidic adducts may have a lower affinity for brevetoxin antibody.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
            <s sid="140">LC/MS data provided structural evidence for the formation of covalent brevetoxin&#8211;cytidine and brevetoxin&#8211;guanosine adducts.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
            <s sid="141">The MS/MS spectrum of each adduct was identified by a parent [M + PbTx-6+H]<sup>+</sup> ion, and two major fragment ions: [M + PbTx-6 &#8211; 132+H], probably formed by elimination of sugar moiety, and [M + PbTx-6 &#8211; 132 &#8211; 18+H], likely due to further loss of water.<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
            <s sid="142">Elimination of respective nucleobase was observed as <italic>m/z</italic> 112 and <italic>m/z</italic> 152 for brevetoxin&#8211;cytidine and brevetoxin&#8211;guanosine, respectively.<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
            <s sid="143">Respective nucleobase imine fragments <italic>m/z</italic> 124 and <italic>m/z</italic> 164 were also observed, indicating that adduction sites of nucleobases toward brevetoxin occurs at least in part on the exocyclic NH<sub>2</sub> groups of the base moieties.<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
            <s sid="144">LC/MS analysis did not yield sufficient structural information to confirm the site of nucleoside linkage to the H-ring epoxide.<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Characterization of brevetoxin&#8211;nucleoside adducts</title>
          <p>
            <s sid="145">Brevetoxin&#8211;nucleoside adducts were examined after <italic>in vitro</italic> exposure of brevetoxins to lung fibroblasts and after <italic>in vivo</italic> exposure of rats to brevetoxins via intratracheal administration.<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
            <s sid="146">Two brevetoxin congeners were chosen for exposure, PbTx-6, which has the H-ring epoxide, and PbTx-2, which has been found to be metabolized to form the H-ring epoxide in liver cells.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
            <s sid="147">Both brevetoxin congeners yielded brevetoxin immunoreactiv-ity to purified nucleoside fractions recovered from exposed lung cells and lung tissue; however, in each case PbTx-2 yielded four times the activity found with PbTx-6 treatment.<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
            <s sid="148">Extracted ion chromatograms identified brevetoxin adducts only with PbTx-2 treatment.<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
            <s sid="149">Brevetoxin&#8211;cytidine adducts were detected in PbTx-2&#8211;exposed lung cells, but no adducts were found in the nucleic acid extracts of lung cells exposed to PbTx-6 under the same LC/MS conditions.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
            <s sid="150">Adducts of brevetoxin&#8211;guanosine <italic>(m/z</italic> 1,194) and brevetoxin&#8211;adenosine (<italic>m/z</italic> 1,178) were identified in the lung of rats exposed to PbTx-2 but not PbTx-6.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs16" novelty="None" advantage="None"/></s>
            <s sid="151">These results are the first to establish the <italic>in vitro</italic> and <italic>in vivo</italic> formation of nucleic acid adducts after brevetoxin exposure.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="152">Although the reactivity of PbTx-2, and not its epoxide PbTx-6, might be taken to mean that the epoxide is not the likely reactive group for conjugation with the nucleoside, further interpretation may indicate otherwise.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
            <s sid="153">PbTx-6 also has the K-ring &#945;,&#946;-unsaturated aldehyde, indicating that it should be as reactive for nucleoside conjugation by Michael addition as PbTx-2, which it is not.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
            <s sid="154">This suggests that epoxidation may be an intermediate step for PbTx-2 adduction.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
            <s sid="155">Epoxides are very aggressive alkylating agents of nucleophilic sites of nucleosides, and epoxides formed metabolically may have a higher probability of binding to DNA.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
            <s sid="156">Hence, an epoxide formed intracellularly by metabolism of PbTx-2 would have greater access to DNA than the epoxide of PbTx-6 when administered into the animal.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
            <s sid="157">DNA adduction to a metabolically formed epoxide of brevetoxin is also consistent with the report that both the single and double reduction of &#945;,&#946;-unsaturated aldehyde derivates of PbTx-2 caused DNA breaks in human lymphocytes as effectively as PbTx-2 (<xref ref-type="bibr" rid="b28-ehp0116-000930">Sayer et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac35" novelty="None" advantage="None"/></s>
            <s sid="158">Adduction of guanosine or adenosine to the epoxide would lead to the brevetoxin&#8211;guanosine and brevetoxin&#8211;adenosine masses <italic>m/z</italic> 1,194 and 1,178, respectively, identified in lung nucleic acid hydrolytes.<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
            <s sid="159">However the K-ring R group &#945;,&#946;-unsaturated aldehyde is also likely to react with the nucleoside.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
            <s sid="160">For example, Michael addition with the nucleoside and subsequent oxidation of the aldehyde to carboxylic acid would also lead to the same mass adduct products.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
            <s sid="161">Additional analysis will be necessary to provide full structural assignments of the brevetoxin&#8211;nucleoside adducts in lung tissues.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
            <s sid="162">The structural assignment of the toxin nucleoside linkage, however, is less critical from a functional perspective, as multiple reaction products are bound to result from brevetoxin reactive intermediates.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
            <s sid="163">It is likely that more sensitive LC/MS techniques will identify additional brevetoxin&#8211;nucleic acid and brevetoxin&#8211;protein adducts in lung.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
            <s sid="164">This is important because, even though major toxin nucleic acid adducts product are necessary for the development of markers of exposure, less prominent adduct products are often responsible for genotoxic effects (<xref ref-type="bibr" rid="b14-ehp0116-000930">Groopman et al. 2005</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Potential for genotoxic effects following red tide exposure</title>
          <p>
            <s sid="165">This study presents the first evidence that brevetoxins form nucleoside adducts in lung tissue.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
            <s sid="166">We identified brevetoxin&#8211;guanosine <italic>(m/z</italic> 1,194) and brevetoxin&#8211;adenosine (<italic>m/z</italic> 1,178) as major products of hydrolyzed lung DNA after intratracheal exposure of rats.<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
            <s sid="167">The finding of brevetoxin conjugated to guanosine and adenosine after hydrolysis of lung DNA is consistent with brevetoxin metabolism resulting in a reactive intermediate capable of reaching the nucleus from its site of metabolism in the mitochondria to react with DNA purines.<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
            <s sid="168">DNA purine adducts are known to be unstable and to undergo depurination.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac36" novelty="None" advantage="None"/></s>
            <s sid="169">The release of the nucleotide base adduct is an indication of a promutagenic lesion.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac37" novelty="None" advantage="None"/></s>
            <s sid="170">Structurally, the lesion in the DNA is the result of an apurinic site that remains in the DNA base sequence.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac38" novelty="None" advantage="None"/></s>
            <s sid="171">The identification of brevetoxin&#8211;nucleotide base (adenine) adduct (<italic>m/z</italic> 1,046) in addition to brevetoxin&#8211;nucleoside (adenosine) adduct (<italic>m/z</italic> 1,178) in rat lung tissue is consistent with the formation of promutagenic lesions after brevetoxin exposure.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
            <s sid="172">Promutagenic lesions resulting from depurination of aflatoxin&#8211;nucleoside adducts are susceptible to faulty repair, causing G to T transversions, which have been shown to result in inactivation of the TP53 tumor-suppressor gene in aflatoxin-associated hepatocarcinoma (<xref ref-type="bibr" rid="b17-ehp0116-000930">Kensler et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac39" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Potential risk of exposure to brevetoxin aerosols</title>
          <p>
            <s sid="173">The risk of brevetoxin adduct formation and resultant depurination is not known.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot7" novelty="None" advantage="None"/></s>
            <s sid="174">Individuals are continually exposed to environmental agents capable of direct adduct formation as well as adduct formation through environmental agents that induce oxidative damage.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac40" novelty="None" advantage="None"/></s>
            <s sid="175">It is possible that exposure to brevetoxins in aerosols, like other inhaled environmental genotoxic carcinogens, including polyacromatic hydrocarbons (<xref ref-type="bibr" rid="b30-ehp0116-000930">Schoket 1999</xref>) and tobacco smoke (<xref ref-type="bibr" rid="b35-ehp0116-000930">Wiencke 2002</xref>), add to the baseline levels of DNA adducts.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac41" novelty="None" advantage="None"/></s>
            <s sid="176">Baseline levels of adducts in humans are estimated to be in the range of 0.1&#8211;1.0 adduct per 10<sup>8</sup> unmodified DNA bases, and this burden can rise by four orders of magnitude in animals exposed to carcinogenic levels of genotoxic agents (<xref ref-type="bibr" rid="b33-ehp0116-000930">Singh and Farmer 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac42" novelty="None" advantage="None"/></s>
            <s sid="177">A question that remains is whether inhalation exposure to brevetoxin aerosols leads to significant lung DNA depurination.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot8" novelty="None" advantage="None"/></s>
            <s sid="178">Key to this question is the rate of brevetoxin adduction to DNA bases in lung and the extent of exposure.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot9" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="179">The identification of brevetoxin&#8211;purine adducts now provides a foundation for biological monitoring of human exposure to such genotoxic environmental agents.<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
            <s sid="180">The dose levels used in these <italic>in vitro</italic> and <italic>in vivo</italic> experiments were not meant to be reflective of human inhalation exposure to brevetoxins, which has been estimated at 3 and 20 ng/hr for red tide events in Florida (2003) and Texas (2000), respectively (<xref ref-type="bibr" rid="b9-ehp0116-000930">Cheng et al. 2005</xref>; <xref ref-type="bibr" rid="b23-ehp0116-000930">Pierce et al. 2005</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
            <s sid="181">Rather, the dosage was high, by several orders of magnitude, to optimize the search for toxin&#8211;nucleoside adducts.<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
            <s sid="182">Dose&#8211;response studies are an important next step, and previous studies have shown that DNA adducts are formed on a linear basis to dose (<xref ref-type="bibr" rid="b6-ehp0116-000930">Buss et al. 1990</xref>).<CoreSc1 atype="GSC" type="Mot" conceptID="Mot10" novelty="None" advantage="None"/></s>
            <s sid="183">However, most biological monitoring studies use readily obtained samples, such as white blood cells for DNA adducts, serum for albumin adducts or urine for nucleotide adducts.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac43" novelty="None" advantage="None"/></s>
            <s sid="184">The release of the nucleotide adduct from target tissue DNA as a result of depurination leads to the adduct elimination in urine.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac44" novelty="None" advantage="None"/></s>
            <s sid="185">Identification of urinary nucleotide adducts using LC/MS has provided a foundation for large-scale monitoring studies of several genotoxic agents (<xref ref-type="bibr" rid="b32-ehp0116-000930">Shuker and Farmer 1992</xref>; <xref ref-type="bibr" rid="b33-ehp0116-000930">Singh and Farmer 2006</xref>) and could prove useful for brevetoxins as well.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot11" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="display-objects">
        <title>Figures</title>
        <fig id="f1-ehp0116-000930" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Schematic diagram showing the intermediary metabolites generated after <italic>in vitro</italic> metabolic bioactivation pathways of brevetoxin-B in rat liver cells.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g001" xlink:type="simple"/>
        </fig>
        <fig id="f2-ehp0116-000930" position="float">
          <label>Figure 2</label>
          <caption>
            <p>RIA of brevetoxin activity recovered from reaction products of PbTx-6 (mean &#177; SD) in the absence (Cont PbTx-6) and presence of guanosine (PbTx&#8211;Guanosine) or cytidine (PbTx&#8211;Cytodine). Incubation of PbTx-6 with individual nucleoside was carried out at 37&#176;C for 18 hr, and brevetoxin products were separated using a C-18 cartridge.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g002" xlink:type="simple"/>
        </fig>
        <fig id="f3-ehp0116-000930" position="float">
          <label>Figure 3</label>
          <caption>
            <p>LC/MS analysis of semisynthesized brevetoxin nucleic acid adducts. Rel Int, relative intensity. (<italic>A</italic>) Extracted ion current (<italic>m/z</italic> 860&#8211;1,400) from total ion chromatograms for brevetoxin&#8211;cytidine, brevetoxin&#8211;guanosine, and unbound PbTx-6. (<italic>B&#8211;D</italic>) Extracted total ion chromatogram, mass spectra, and product for brevetoxin&#8211;cytidine (<italic>B</italic>), brevetoxin&#8211;guanosine (<italic>C</italic>), and unbound PbTx-6 (<italic>D</italic>). The brevetoxin-adduct fragment patterns shown in (<italic>B</italic>) and (<italic>C</italic>) depict a hypothetical nucleoside linkage to the epoxide to illustrate potential nucleoside fragmentation.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g003" xlink:type="simple"/>
        </fig>
        <fig id="f4-ehp0116-000930" position="float">
          <label>Figure 4</label>
          <caption>
            <p>LC/MS of brevetoxin&#8211;nucleic acid adducts formed by reaction of PbTx-2 with isolated rat lung cells shown as extracted ion current (<italic>m/z</italic> 860&#8211;1,400) from (<italic>A</italic>) a total ion chromatogram, (<italic>B</italic>) mass spectra, and (<italic>C</italic>) product ion spectra. Rel Int, relative intensity. The spectra shows brevetoxin&#8211;cytidine adduct molecule (<italic>m/z</italic> 1,154) and products (<italic>m/z</italic> 1,022, <italic>m/z</italic> 124, and <italic>m/z</italic> 112) resulting from fragmentation of the nucleoside. The brevetoxin adduct fragment pattern shown depicts a hypothetical nucleoside linkage to the epoxide to illustrate potential nucleoside fragmentation.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g004" xlink:type="simple"/>
        </fig>
        <fig id="f5-ehp0116-000930" position="float">
          <label>Figure 5</label>
          <caption>
            <p>RIA of brevetoxin activity retained in lung tissues or associated with DNA extracts 24 hr after <italic>in vivo</italic> exposures to PbTx-2 or PbTx-6. Data shown are mean &#177; SD of PbTx-3 equivalents.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g005" xlink:type="simple"/>
        </fig>
        <fig id="f6-ehp0116-000930" position="float">
          <label>Figure 6</label>
          <caption>
            <p>LC/MS of brevetoxin&#8211;nucleic acid adducts formed by brevetoxin reaction in rat lung after intratracheal exposure. Rel Int, relative intensity. (<italic>A&#8211;C</italic>) Extracted ion current (<italic>m/z</italic> 860&#8211;1,400) from total ion chromatograms, mass spectra, and product ion spectra for (<italic>A</italic>) brevetoxin&#8211;guanosine <italic>m/z</italic> 1,194, (<italic>B</italic>) brevetoxin&#8211;adenine <italic>m/z</italic> 1046, and (<italic>C</italic>) brevetoxin&#8211;adenosine <italic>m/z</italic> 1,178, respectively. The brevetoxin adduct fragment patterns shown in the spectra of (<italic>A&#8211;C</italic>) depict a hypothetical nucleoside linkage to the epoxide to illustrate potential nucleoside or nucleotide fragmentation.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11068.g006" xlink:type="simple"/>
        </fig>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>We thank J. Pritchett (IAS Inc., Burlingame, CA) for mass spectrometry analyses.</p>
          <p>This work was performed while F.F.Y.R held a National Research Council Associateship Award at the Marine Biotoxins Program, NOAA/NOS/CCE-HBR. This work was funded by the National Oceanic and Atmospheric Administration/National Ocean Service (NOAA/NOS).</p>
          <p>The NOS does not approve, recommend, or endorse any proprietary product or material mentioned in this publication. No reference shall be made to NOS, or to this publication furnished by NOS, in any advertising or sales promotion which would indicate or imply that NOS approves, recommends, or endorses any proprietary product or proprietary material mentioned herein or which has as its purpose any intent to cause directly or indirectly the advertised product to be used or purchased because of NOS publication.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>REFERENCES</title>
        <ref id="b1-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Abraham</surname>
                <given-names>WM</given-names>
              </name>
              <name name-style="western">
                <surname>Bourdelais</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Sabater</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Lee</surname>
                <given-names>TA</given-names>
              </name>
              <name name-style="western">
                <surname>Serebriakov</surname>
                <given-names>I</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Airway responses to aerosolized brevetoxins in an animal model of asthma</article-title>
            <source>Am J Respir Crit Care Med</source>
            <volume>171</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <lpage>34</lpage>
          </citation>
        </ref>
        <ref id="b2-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Backer</surname>
                <given-names>LC</given-names>
              </name>
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Rowan</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Cheng</surname>
                <given-names>Y-S</given-names>
              </name>
              <name name-style="western">
                <surname>Benson</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Pierce</surname>
                <given-names>RH</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>Recreational exposure to aerosolized brevetoxins during Florida red tide events</article-title>
            <source>Harmful Algae</source>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <lpage>28</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Backer</surname>
                <given-names>LC</given-names>
              </name>
              <name name-style="western">
                <surname>Kirkpatrick</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Cheng</surname>
                <given-names>YS</given-names>
              </name>
              <name name-style="western">
                <surname>Pierce</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Bean</surname>
                <given-names>JA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population</article-title>
            <source>Environ Health Perspect</source>
            <volume>113</volume>
            <fpage>644</fpage>
            <lpage>649</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Benson</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Tischler</surname>
                <given-names>DL</given-names>
              </name>
              <name name-style="western">
                <surname>Baden</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Uptake, tissue distribution, and excretion of brevetoxin 3 administered to rats by intratracheal instillation</article-title>
            <source>J Toxicol Environ Health A</source>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>345</fpage>
            <lpage>355</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bossart</surname>
                <given-names>GD</given-names>
              </name>
              <name name-style="western">
                <surname>Baden</surname>
                <given-names>DG</given-names>
              </name>
              <name name-style="western">
                <surname>Ewing</surname>
                <given-names>RY</given-names>
              </name>
              <name name-style="western">
                <surname>Roberts</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Wright</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <year>1998</year>
            <article-title>Brevetoxicosis in manatees (<italic>Trichechus manatus latirostris</italic>) from the 1996 epizootic: gross, histologic, and immunohisto-chemical features</article-title>
            <source>Toxicol Pathol</source>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>276</fpage>
            <lpage>282</lpage>
          </citation>
        </ref>
        <ref id="b6-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Buss</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Caviezel</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Lutz</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <year>1990</year>
            <article-title>Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1</article-title>
            <source>Carcinogenesis</source>
            <volume>11</volume>
            <issue>12</issue>
            <fpage>2133</fpage>
            <lpage>2135</lpage>
          </citation>
        </ref>
        <ref id="b7-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Castell</surname>
                <given-names>JV</given-names>
              </name>
              <name name-style="western">
                <surname>Donato</surname>
                <given-names>MT</given-names>
              </name>
              <name name-style="western">
                <surname>Gomez-Lechon</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach</article-title>
            <source>Exp Toxicol Pathol</source>
            <volume>57</volume>
            <issue>suppl 1</issue>
            <fpage>189</fpage>
            <lpage>204</lpage>
          </citation>
        </ref>
        <ref id="b8-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Catterall</surname>
                <given-names>WA</given-names>
              </name>
              <name name-style="western">
                <surname>Risk</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>1981</year>
            <article-title>Toxin T4(6) from <italic>Ptychodiscus brevis</italic> (formerly <italic>Gymnodinium breve</italic>) enhances activation of voltage-sensitive sodium channels by veratridine</article-title>
            <source>Mol Pharmacol</source>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>345</fpage>
            <lpage>348</lpage>
          </citation>
        </ref>
        <ref id="b9-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cheng</surname>
                <given-names>YS</given-names>
              </name>
              <name name-style="western">
                <surname>Villareal</surname>
                <given-names>TA</given-names>
              </name>
              <name name-style="western">
                <surname>Zhou</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Gao</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Pierce</surname>
                <given-names>RH</given-names>
              </name>
              <name name-style="western">
                <surname>Wetzel</surname>
                <given-names>D</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Characterization of red tide aerosol on the Texas coast</article-title>
            <source>Harmful Algae</source>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <lpage>94</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chou</surname>
                <given-names>H-N</given-names>
              </name>
              <name name-style="western">
                <surname>Shimizu</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Van Duyne</surname>
                <given-names>G</given-names>
              </name>
              <name name-style="western">
                <surname>Clardy</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <year>1985</year>
            <article-title>Isolation and structures of two new polycyclic ethers from <italic>Gymnodinium breve</italic> Davis (<italic>Ptychodiscus brevis</italic>)</article-title>
            <source>Tetrahedron Lett</source>
            <volume>26</volume>
            <issue>24</issue>
            <fpage>2865</fpage>
          </citation>
        </ref>
        <ref id="b11-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <year>1948</year>
            <article-title><italic>Gymnodinium breve</italic>: a cause of discolored water and animal mortality in the Gulf of Mexico</article-title>
            <source>Bot Gaz</source>
            <volume>109</volume>
            <fpage>358</fpage>
            <lpage>360</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Kirkpatrick</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Backer</surname>
                <given-names>LC</given-names>
              </name>
              <name name-style="western">
                <surname>Bean</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Wanner</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Reich</surname>
                <given-names>A</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Aerosolized red-tide toxins (brevetoxins) and asthma</article-title>
            <source>Chest</source>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>187</fpage>
            <lpage>194</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Garthwaite</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Ross</surname>
                <given-names>KM</given-names>
              </name>
              <name name-style="western">
                <surname>Miles</surname>
                <given-names>CO</given-names>
              </name>
              <name name-style="western">
                <surname>Briggs</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>Towers</surname>
                <given-names>NR</given-names>
              </name>
              <name name-style="western">
                <surname>Borrell</surname>
                <given-names>T</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2001</year>
            <article-title>Integrated enzyme-linked immunosorbent assay screening system for amnesic, neurotoxic, diarrhetic, and paralytic shellfish poisoning toxins found in New Zealand</article-title>
            <source>J AOAC Int</source>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>1643</fpage>
            <lpage>1648</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Groopman</surname>
                <given-names>JD</given-names>
              </name>
              <name name-style="western">
                <surname>Johnson</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Kensler</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk</article-title>
            <source>Cancer Biomark</source>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <lpage>14</lpage>
          </citation>
        </ref>
        <ref id="b15-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hertzog</surname>
                <given-names>PJ</given-names>
              </name>
              <name name-style="western">
                <surname>Lindsay-Smith</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Garner</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <year>1980</year>
            <article-title>A high pressure liquid chromatography study on the removal of DNA- bound aflatoxin B<sub>1</sub> in rat liver and <italic>in vitro</italic></article-title>
            <source>Carcinogenesis</source>
            <volume>1</volume>
            <fpage>787</fpage>
            <lpage>793</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Wu</surname>
                <given-names>CH</given-names>
              </name>
              <name name-style="western">
                <surname>Baden</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <year>1984</year>
            <article-title>Depolarizing action of a red-tide dinoflagellate brevetoxin on axonal membranes</article-title>
            <source>J Pharmacol Exp Ther</source>
            <volume>229</volume>
            <issue>2</issue>
            <fpage>615</fpage>
            <lpage>621</lpage>
          </citation>
        </ref>
        <ref id="b17-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kensler</surname>
                <given-names>TW</given-names>
              </name>
              <name name-style="western">
                <surname>Qian</surname>
                <given-names>GS</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>JG</given-names>
              </name>
              <name name-style="western">
                <surname>Groopman</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Translational strategies for cancer prevention in liver</article-title>
            <source>Nat Rev Cancer</source>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>321</fpage>
            <lpage>329</lpage>
          </citation>
        </ref>
        <ref id="b18-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kirkpatrick</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Backer</surname>
                <given-names>LC</given-names>
              </name>
              <name name-style="western">
                <surname>Bean</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Tamer</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Kirkpatrick</surname>
                <given-names>G</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Environmental exposures to Florida red tides: effects on emergency room respiratory diagnoses admissions</article-title>
            <source>Harmful Algae</source>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>526</fpage>
            <lpage>533</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Koskinen</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Plna</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo</article-title>
            <source>Chem Biol Interact</source>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <lpage>229</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lin</surname>
                <given-names>Y-Y</given-names>
              </name>
              <name name-style="western">
                <surname>Risk</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Ray</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Van Engen</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Clardy</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Golik</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1981</year>
            <article-title>Isolation and structure of brevetoxin B from the &#8220;red tide&#8221; dinoflagellate <italic>Ptychodiscus brevis</italic> (<italic>Gymnodinium breve</italic>)</article-title>
            <source>J Am Chem Soc</source>
            <volume>103</volume>
            <fpage>6773</fpage>
            <lpage>6775</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>McFarren</surname>
                <given-names>EF</given-names>
              </name>
              <name name-style="western">
                <surname>Tanabe</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Silva</surname>
                <given-names>FJ</given-names>
              </name>
              <name name-style="western">
                <surname>Wilson</surname>
                <given-names>WB</given-names>
              </name>
              <name name-style="western">
                <surname>Campbell</surname>
                <given-names>JE</given-names>
              </name>
              <name name-style="western">
                <surname>Lewis</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <year>1965</year>
            <article-title>The occurrence of a ciguatera-like poison in oysters, clams, and <italic>Gymnodinium breve</italic> cultures</article-title>
            <source>Toxicon</source>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <lpage>123</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Medinsky</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Benson</surname>
                <given-names>JM</given-names>
              </name>
              <name name-style="western">
                <surname>Hobbs</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <article-title>Lung clearance and disposition of <sup>63</sup>Ni in F344/N rats after intra-tracheal instillation of nickel sulfate solutions</article-title>
            <source>Environ Res</source>
            <volume>43</volume>
            <fpage>168</fpage>
            <lpage>178</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pierce</surname>
                <given-names>RH</given-names>
              </name>
              <name name-style="western">
                <surname>Henry</surname>
                <given-names>MS</given-names>
              </name>
              <name name-style="western">
                <surname>Blum</surname>
                <given-names>PC</given-names>
              </name>
              <name name-style="western">
                <surname>Hamel</surname>
                <given-names>SL</given-names>
              </name>
              <name name-style="western">
                <surname>Kirkpatrick</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Cheng</surname>
                <given-names>YS</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Brevetoxin composition in water and marine aerosol along a Florida beach: assessing potential human exposure to marine biotoxins</article-title>
            <source>Harmful Algae</source>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>965</fpage>
            <lpage>972</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Radwan</surname>
                <given-names>FF</given-names>
              </name>
              <name name-style="western">
                <surname>Ramsdell</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Characterization of in vitro oxidative and conjugative metabolic pathways for brevetoxin (PbTx-2)</article-title>
            <source>Toxicol Sci</source>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <lpage>65</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Radwan</surname>
                <given-names>FF</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Ramsdell</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Identification of a rapid detoxification mechanism for brevetoxin in rats</article-title>
            <source>Toxicol Sci</source>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>839</fpage>
            <lpage>846</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp0116-000930">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ramsdell</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <person-group person-group-type="editor">
              <name name-style="western">
                <surname>Botana</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>The molecular and integrative basis to brevetoxin toxicity</article-title>
            <source>Seafood and Freshwater Toxins; Pharmacology, Physiology and Detection</source>
            <publisher-loc>London</publisher-loc>
            <publisher-name>Taylor &amp; Francis</publisher-name>
            <fpage>519</fpage>
            <lpage>550</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Risk</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Lin</surname>
                <given-names>YY</given-names>
              </name>
              <name name-style="western">
                <surname>Sadagopa Ramanujam</surname>
                <given-names>VM</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>LL</given-names>
              </name>
              <name name-style="western">
                <surname>Ray</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Trieff</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <year>1979</year>
            <article-title>High pressure liquid chromatographic separation of two major toxic compounds from <italic>Gymnodinium breve</italic> Davis</article-title>
            <source>J Chromatogr Sci</source>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>400</fpage>
            <lpage>405</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sayer</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Hu</surname>
                <given-names>Q</given-names>
              </name>
              <name name-style="western">
                <surname>Bourdelais</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Baden</surname>
                <given-names>DG</given-names>
              </name>
              <name name-style="western">
                <surname>Gibson</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes</article-title>
            <source>Arch Toxicol</source>
            <volume>79</volume>
            <issue>11</issue>
            <fpage>683</fpage>
            <lpage>688</lpage>
          </citation>
        </ref>
        <ref id="b29-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sayer</surname>
                <given-names>AN</given-names>
              </name>
              <name name-style="western">
                <surname>Hu</surname>
                <given-names>Q</given-names>
              </name>
              <name name-style="western">
                <surname>Bourdelais</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Baden</surname>
                <given-names>DG</given-names>
              </name>
              <name name-style="western">
                <surname>Gibson</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>The inhibition of CHO-K1-BH4 cell proliferation and induction of chromosomal aberrations by brevetoxins in vitro</article-title>
            <source>Food Chem Toxicol</source>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>1082</fpage>
            <lpage>1091</lpage>
          </citation>
        </ref>
        <ref id="b30-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Schoket</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>DNA damage in humans exposed to environmental and dietary polycyclic aromatic hydrocarbons</article-title>
            <source>Mutat Res</source>
            <volume>424</volume>
            <issue>1&#8211;2</issue>
            <fpage>143</fpage>
            <lpage>153</lpage>
          </citation>
        </ref>
        <ref id="b31-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shimizu</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Chou</surname>
                <given-names>HN</given-names>
              </name>
              <name name-style="western">
                <surname>Bando</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <article-title>Structure of brevetoxin A (GB-1 toxin), the most potent toxin in the Florida red tide organism <italic>Gymnodinium breve</italic> (<italic>Ptychodiscus brevis</italic>)</article-title>
            <source>J Am Chem Soc</source>
            <volume>108</volume>
            <fpage>514</fpage>
            <lpage>515</lpage>
          </citation>
        </ref>
        <ref id="b32-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Shuker</surname>
                <given-names>DE</given-names>
              </name>
              <name name-style="western">
                <surname>Farmer</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <year>1992</year>
            <article-title>Relevance of urinary DNA adducts as markers of carcinogen exposure</article-title>
            <source>Chem Res Toxicol</source>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <lpage>460</lpage>
          </citation>
        </ref>
        <ref id="b33-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Farmer</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection</article-title>
            <source>Carcinogenesis</source>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>178</fpage>
            <lpage>196</lpage>
          </citation>
        </ref>
        <ref id="b34-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Plakas</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>El Said</surname>
                <given-names>KR</given-names>
              </name>
              <name name-style="western">
                <surname>Jester</surname>
                <given-names>EL</given-names>
              </name>
              <name name-style="western">
                <surname>Granade</surname>
                <given-names>HR</given-names>
              </name>
              <name name-style="western">
                <surname>Dickey</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>LC/MS analysis of brevetoxin metabolites in the Eastern oyster (<italic>Crassostrea virginica</italic>)</article-title>
            <source>Toxicon</source>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <lpage>465</lpage>
          </citation>
        </ref>
        <ref id="b35-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wiencke</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>DNA adduct burden and tobacco carcinogenesis</article-title>
            <source>Oncogene</source>
            <volume>21</volume>
            <issue>48</issue>
            <fpage>7376</fpage>
            <lpage>7391</lpage>
          </citation>
        </ref>
        <ref id="b36-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Woodcock</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>1948</year>
            <article-title>Note concerning human respiratory irritation associated with high concentrations of plankton and mass mortality of marine organisms</article-title>
            <source>J Mar Res</source>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <lpage>62</lpage>
          </citation>
        </ref>
        <ref id="b37-ehp0116-000930">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Woofter</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Dechraoui</surname>
                <given-names>MY</given-names>
              </name>
              <name name-style="western">
                <surname>Garthwaite</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Towers</surname>
                <given-names>NR</given-names>
              </name>
              <name name-style="western">
                <surname>Gordon</surname>
                <given-names>CJ</given-names>
              </name>
              <name name-style="western">
                <surname>Cordova</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>Measurement of brevetoxin levels by radioimmunoassay of blood collection cards after acute, long-term, and low-dose exposure in mice</article-title>
            <source>Environ Health Perspect</source>
            <volume>111</volume>
            <fpage>1595</fpage>
            <lpage>1600</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>